tiprankstipranks
NeoGenomics backs FY24 revenue view $650M-$660M, consensus $654.56M
PremiumThe FlyNeoGenomics backs FY24 revenue view $650M-$660M, consensus $654.56M
3M ago
NeoGenomics reports Q1 EPS (21c), consensus (5c)
PremiumThe Fly
NeoGenomics reports Q1 EPS (21c), consensus (5c)
3M ago
Is NEO a Buy, Before Earnings?
PremiumPre-Earnings
Is NEO a Buy, Before Earnings?
3M ago
NeoGenomics price target raised to $19 from $17 at Goldman Sachs
PremiumThe FlyNeoGenomics price target raised to $19 from $17 at Goldman Sachs
5M ago
NeoGenomics price target raised to $23 from $21 at BTIG
PremiumThe Fly
NeoGenomics price target raised to $23 from $21 at BTIG
5M ago
NeoGenomics reports Q4 non-GAAP EPS 3c, consensus (2c)
PremiumThe Fly
NeoGenomics reports Q4 non-GAAP EPS 3c, consensus (2c)
5M ago
NeoGenomics price target lowered to $21 from $25 at BTIG
PremiumThe FlyNeoGenomics price target lowered to $21 from $25 at BTIG
7M ago
Natera price target raised to $85 from $75 at BTIG
PremiumThe Fly
Natera price target raised to $85 from $75 at BTIG
7M ago
NeoGenomics price target lowered to $18 from $19 at BofA
PremiumThe Fly
NeoGenomics price target lowered to $18 from $19 at BofA
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100